Ultrasound-guided endometrial preparation for endometriosis
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether a 2-3 month hormone treatment before a frozen embryo transfer improves pregnancy success in women with deep endometriosis. It may help your body prepare better for the embryo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 39 years old.
- You have deep endometriosis confirmed by ultrasound at the study center.
- This is your first frozen embryo transfer cycle using hormone therapy to prepare the lining.
- You have at least one good-quality frozen embryo available.
- You agree to join the study and sign a consent form.
- You do not have other uterine problems (like fibroids, adhesions, or abnormal shape) or conditions that would make hormone therapy unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether adding micronized progesterone during frozen embryo transfer cycles helps support embryo implantation and pregnancy. You may benefit if your care team is already preparing the uterus with hormone therapy for a blastocyst transfer.
This trial explores how natural uterine contractions affect pregnancy success in women using hormone therapy for frozen embryo transfer. It may help doctors understand if uterine activity influences implantation.
This trial compares a new method to time a frozen embryo transfer (using a test called ERA) with the standard method. The goal is to find the best time to transfer a high-quality embryo in women who have had multiple failed IVF attempts (recurrent implantation failure).
This trial studies whether giving a GnRH “downshifting” shot before transferring a frozen embryo can improve pregnancy outcomes for people with endometriosis or adenomyosis. It may help by changing hormone activity before the transfer.
This trial studies whether adjusting the length of pre-treatment with a hormone blocker (GnRH agonist) and adding letrozole before a frozen embryo transfer can improve pregnancy outcomes for people with adenomyosis.
This trial tests a drug called GnRH agonist to see if it helps people with endometriosis cysts. It might offer a new treatment option for those with this condition.
Hear when a new Deep Infiltrating Endometriosis (DIE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.